Sign The Petition

Diversity, Equity, & Equality

We need your support! Join the fight to ensure 30% of medical cannabis licenses in Maryland are awarded to African Americans!

Diversity

In an industry that is on track to make billions, less than 1% of African Americans in Maryland are awarded highly coveted medical cannabis licenses. The members of the community most affected by the war on drugs are profiting the least from an industry that offers options for pain management.

Equity

The 2018 House Bill (HB2) was designed to solve this lack of diversity and level the playing field by mandating the Maryland Medical Cannabis Commission (MMCC) to seek and award diverse members with licenses to participate in the wealth of legalization. Their implementation of this mandate is being questioned as diverse applicants are being rejected.

Equality

Here at RemiLeaf, we are dedicated to ensuring that 30% of medical cannabis licenses are given to African Americans. We rally together to promote equal opportunity to grow the crop! Join us in upholding the spirit of House Bill (HB2).

Our story

There have been significant issues and concerns raised about the process being used to determine winners and losers for these new licenses. Those concerns reached a tipping point as a result of the letters sent to those identified as top tier applicants, and those who have been rejected by the Commission for either a grower or processor license. Help us make a change by signing our petition below!

Equity in Cannabis

As cannabis continues to be legalized across the United States, a multibillion dollar industry has been born. In 2013, Maryland became the 21st state to legalize the use of medical cannabis, what is missing from Maryland’s booming industry and across the nation are people of color. For decades African American families and communities have been marginalized and displaced by disparate treatment during the war on drugs. Yet, African Americans are now the least to benefit economically and socially from the profits created by the legalization of cannabis.

Although cannabis remains a Schedule I drug under the federal Controlled Substance Act (CSA), meaning it is federally illegal to manufacture, distribute, possess or use cannabis; Maryland has legalized the use and production of cannabis for medical purposes. Now that marijuana is seen as a legitimate business in Maryland, those whose lives have been most impacted by the war on drugs have not been able to reap any of the profits as business owners, and their communities have seen no economic benefit from the thriving cannabis industry.

Research has repeatedly shown that minorities and African Americans particularly, are far more frequently arrested on drug charges even as they use drugs at roughly the same rate as white people. Minorities also are more likely to receive harsh sentences for minor drug crimes. With legal marijuana now one of the country’s fastest-growing industries, who profits is as much of a civil rights question as who gets punished.

Maryland’s moral challenge as well as the industry nationally, is to ensure that African Americans who have suffered the most under the drug wars and have been systematically excluded as a result of bias, lack of political influence, legacy wealth and power have a fair and equal opportunity to participate in this industry and to enjoy and share the wealth of legalization.

In 2018, House Bill 2 (HB2) was created to help resolve the racial disparity in Maryland’s cannabis industry that resulted from the selection of the grower, processor and dispensary licensees in 2015 that disproportionately benefited non-minorities. HB2 addressed the lack of minority and women lead businesses by adding 4 new grower licenses and 10 new processor licenses and directed the Maryland Medical Cannabis Commission (MMCC) to actively seek racial, gender, ethnic and geographic diversity in their award. The MMCC was instructed to implement remedial regulations based on the results of a 2018 disparity report ordered by the Governor. The disparity study concluded that there is strong evidence, consisting of both quantitative and qualitative findings that support the use of race and gender based measures to remediate discrimination affecting minority and women owned businesses in the types of industry relevant to the medical cannabis business.

It is essential that Maryland bring overdue relief to those whose lives have been destroyed by the war on drugs and the heavy hands of the criminal justice system. MMCC must comply with the legislative mandate of HB2 to help end and correct the gross racial inequities and injustices that have come to describe and define Maryland’s medical cannabis industry. The licenses created under HB2 were created to address this issue. It is time that Maryland increases the diversity in its medical cannabis industry, level the playing field, and comply with the legislative mandate of inclusion.

We need your support! Join the fight to ensure 30% of medical cannabis licenses in Maryland are awarded to African Americans!

Less than 1% of African Americans in Maryland are awarded the highly coveted Medical Cannabis Licenses. As a result, African Americans are systematically being left out of owning licenses in and industry that is on track to make BILLIONS in Maryland! Join RemiLeaf to fight this injustice so we can have equal opportunity to grow the crop!

Date and Time

Thursday, December 5, 2019
8:30am - 11:30am EST

Location

The Sidewalks of the Circuit Court Anne Arundel Court
8 Church Circle
Annapolis, MD 21401